In part one of this four-part series regarding rare diseases, the author explores how rare disease treatment development evolved from a niche area to a cornerstone of biopharma growth.
Nathan Edwards, PhD
Advertisement
Nathan Edwards, PhD, specializes in business development, new product planning, and early brand strategy. He helps companies lay the foundation for successful launches through data-backed strategies spanning indication assessment to portfolio strategy. With a strong background in pricing and market access, Nathan integrates both commercial and access insights into early asset development to maximize market opportunity.
Articles by Nathan Edwards, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
How Digitalization Is Transforming Pharmaceutical Manufacturing Processes
3
How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs
4
GSK’s RSV Vaccine Approved in Europe
5